BOULDER, Colo., Jan. 11, 2017 -- Boomtown, a startup accelerator that nurtures selected startups through a 12-week mentoring program, is excited to announce that they have established a relationship with the Colorado BioScience Association (CBSA).
As a result of the recently-developed partnership, all Boomtown alumni and teams in health tech will be provided with a 12-month, complimentary membership to CBSA.
“We are incredibly excited to deepen our relationship with CBSA,” said Tom Base, Managing Director, HealthTech at Boomtown. “This is just one of the ways that CBSA and Boomtown continue to collaborate in order to support entrepreneurs in healthcare innovation.”
Colorado BioScience Association serves as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. Representing more than 350 member organizations, CBSA strives to advance the industry throughout the state of Colorado as well as the Rocky Mountain region.
“Startups typically have limited funds to join industry organizations such as ours but are, at the same time, the very ones that would most benefit from our resources,” said April Giles, CBSA CEO. “This partnership provides us access to Boomtown healthcare startups that we can support to hopefully become thriving and viable companies.”
About Boomtown
Based in Boulder, Colo., Boomtown aims to discover and support promising Internet, mobile, software, Internet of Things (IoT) and HealthTech startups. Boomtown is currently launching its seventh Internet and Mobile and third HealthTech classes and has graduated more than 50 companies since founding in 2013. For more information, visit www.boomtownboulder.com.
About Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.
Contact: Jackie Daane [email protected] 734-277-7006


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



